...
首页> 外文期刊>Rheumatology international. >Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome
【24h】

Etanercept and anakinra can prolong febrile episodes in patients with hyperimmunoglobulin D and periodic fever syndrome

机译:Etanercept和anakinra可以延长高免疫球蛋白D和周期性发热综合征患者的发热发作

获取原文
获取原文并翻译 | 示例

摘要

Hyperimmunoglobulin D and periodic fever syndrome (HIDS) is a rare, hereditary autoinflammatory condition, characterized by recurrent inflammatory episodes. There is no proven treatment for HIDS, but various drugs including, non-steroidal anti-inflammatory drugs, colchicine, steroids, statins and thalidomide have all been tried. Recently, some patients have demonstrated a good clinical response to either etanercept or anakinra. We report a case of a 10-year-old girl who experienced prolonged and severe inflammatory attacks, when she was treated with etanercept, and later with anakinra.
机译:高免疫球蛋白D和周期性发热综合征(HIDS)是一种罕见的遗传性自体炎症,其特征是反复发作的炎症发作。目前尚无针对HIDS的可靠治疗方法,但已尝试了多种药物,包括非甾体类抗炎药,秋水仙碱,类固醇,他汀类药物和沙利度胺。近来,一些患者已证明对依那西普或阿那那克有良好的临床反应。我们报道了一例10岁的女孩,她在接受etanercept以及后来的anakinra治疗后经历了长期而严重的炎症发作。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号